| Dr Wendall F Gaston, RPH | |
|
1930 Illinois St, Sidney, NE 69162-1427 | |
| (308) 254-4531 | |
| (308) 254-1182 |
| Full Name | Dr Wendall F Gaston |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1930 Illinois St, Sidney, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568762656 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 8677 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Wendall F Gaston, RPH 1930 Illinois St, Sidney, NE 69162-1427 Ph: (308) 254-4531 | Dr Wendall F Gaston, RPH 1930 Illinois St, Sidney, NE 69162-1427 Ph: (308) 254-4531 |
News Archive
A targeted cancer drug given with low-dose chemotherapy shrank ovarian tumors and slowed progression of ovarian cancer in patients with recurrent disease, according to research findings presented by Agustin Garcia, M.D., principal investigator of the study and Director of Breast Cancer Research at the Women's Cancer Research Institute at the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center.
PRA International, a leading Clinical Research Organization, announces it has entered into a partnership agreement with Oncopartners, a leading Latin American oncology development company, and its exclusive partner IBPC, a non-profit oncology research network comprised of Brazil's largest public oncology hospitals which collectively treat an estimated 140,000 new incidences of cancer annually.
EraGen Biosciences Inc. today announced that it will host a corporate workshop at the upcoming Clinical Virology Symposium, which is being held May 8-11 in Daytona Beach, Fla. The workshop will take place at 1 p.m. on Tuesday, May 10, at the Ocean Center in Daytona Beach.
Janssen Research & Development, LLC (JRD) announced today that the U.S. Food and Drug Administration (FDA) has assigned a Priority Review designation to the supplemental New Drug Application (sNDA) filed on December 29, 2011 for XARELTO (rivaroxaban), an oral anticoagulant, to reduce the risk of thrombotic cardiovascular events in patients with Acute Coronary Syndrome (ACS).
› Verified 4 days ago
Victoria Brauer, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3001 Silverberg Dr, Sidney, NE 69162 Phone: 308-254-9149 | |
Silvano Axel, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1944 Illinios St, Sidney, NE 69162 Phone: 308-254-4531 Fax: 308-254-1182 | |
Michael Patrick Hicks, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1944 Illinois St, Sidney, NE 69162 Phone: 308-254-4531 | |
Alexander T Kanack, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3001 Silverberg Dr, Sidney, NE 69162 Phone: 308-254-9149 | |
Dr. Emily Johnson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1000 Pole Creek Xing, Sidney, NE 69162 Phone: 308-249-5496 | |
Dr. Jesse Robinson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1944 Illinois St, Sidney, NE 69162 Phone: 308-254-4767 | |
Dr. John Patrick Mildenberger, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1000 Pole Creek Xing, Sidney, NE 69162 Phone: 308-254-7268 |